SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-278495
Filing Date
2017-09-07
Accepted
2017-09-07 07:27:57
Documents
3
Period of Report
2017-09-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d434005d8k.htm 8-K 17201
2 EX-99.1 d434005dex991.htm EX-99.1 28341
3 GRAPHIC g434005g0907152458870.jpg GRAPHIC 3280
  Complete submission text file 0001193125-17-278495.txt   51355
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 171072868
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1